Stock Events

Stock Events

SanBio Company Limited 

$5.48
11
+$0+0% Friday 20:00

Statistics

Day High
2.81
Day Low
2.81
52W High
5.48
52W Low
2.81
Volume
211
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

12JunExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.15
-0.1
-0.05
0
Expected EPS
-0.0390205809
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-37.4MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNBOY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biogen
BIIB
Mkt Cap22.63B
Biogen Inc. focuses on the discovery, development, and delivery of therapies for neurological and neurodegenerative diseases, competing directly with SanBio's regenerative solutions for neurological conditions.
Novartis
NVS
Mkt Cap237.61B
Novartis AG operates in the pharmaceuticals sector, including treatments for neurological conditions similar to those targeted by SanBio, making it a direct competitor in the neurology healthcare market.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. is involved in the development and commercialization of medicines and vaccines, including for neurological diseases, competing with SanBio's offerings in the healthcare market.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. focuses on the development of medicines in areas of unmet medical need, including neurological conditions, positioning it as a competitor to SanBio.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. provides healthcare solutions, including for neurological diseases, making it a competitor in the same therapeutic area as SanBio.
Rogers
ROG
Mkt Cap1.57B
Roche Holding AG engages in the pharmaceuticals and diagnostics business, including neurology and neurodegenerative diseases, directly competing with SanBio's focus areas.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie Inc. researches and develops pharmaceutical products, including for neurological disorders, competing in the same market as SanBio.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. focuses on areas of high unmet medical need, including neurology, which pits it against SanBio in the competition for treatments in this area.
Lilly(Eli) &
LLY
Mkt Cap772.28B
Eli Lilly and Company is engaged in the discovery, development, and marketing of pharmaceutical products for neurological conditions, directly competing with SanBio.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC operates in the biopharmaceutical industry, focusing on innovative medicines, including for neurological diseases, making it a competitor to SanBio.

About

SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes, age-related macular degeneration, retinitis pigments, spinal cord injury, Parkinson's disease, Alzheimer's disease, and others; SB618 for peripheral nerve damage; SB308 for muscular dystrophy disease; MSC1 for cancer; and MSC2 for inflammatory disease and optic neuritis. The company was founded in 2001 and is headquartered in Tokyo, Japan.
Show more...
CEO
Mr. Toru Kawanishi
Employees
29
Country
JP
ISIN
US7995731004

Listings

OTC Link
US
SNBIF
TSE
JP
4592.TSE
OTC Link
US
SNBOY

0 Comments

Share your thoughts

FAQ

What is SanBio Company Limited stock price today?▼
The current price of SNBOY is $5.48 USD — it has increased by +0% in the past 24 hours. Watch SanBio Company Limited stock price performance more closely on the chart.
What is SanBio Company Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange SanBio Company Limited stocks are traded under the ticker SNBOY.
When is the next SanBio Company Limited earnings date?▼
SanBio Company Limited is going to release the next earnings report on June 12, 2026.
What were SanBio Company Limited earnings last quarter?▼
SNBOY earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.13 USD resulting in a +28.48% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is SanBio Company Limited revenue for the last year?▼
SanBio Company Limited revenue for the last year amounts to 0 USD.
What is SanBio Company Limited net income for the last year?▼
SNBOY net income for the last year is -37.4M USD.
How many employees does SanBio Company Limited have?▼
As of April 03, 2026, the company has 29 employees.
In which sector is SanBio Company Limited located?▼
SanBio Company Limited operates in the Health Care sector.
When did SanBio Company Limited complete a stock split?▼
SanBio Company Limited has not had any recent stock splits.
Where is SanBio Company Limited headquartered?▼
SanBio Company Limited is headquartered in Tokyo, JP.